Stratification Using ECOG, ADL and HCT-CI Scales, but Not CGA Enables Identifying Elderly AML Patients Fit for Intensive Chemotherapy - a Multicenter Study from Polish Adult Leukemia Group
Bożena Katarzyna Budziszewska(Instytut Hematologii i Transfuzjologi), Ewa Lech‐Marańda(Instytut Hematologii i Transfuzjologi), Agnieszka Wierzbowska(Medical University of Lodz), Agnieszka Piekarska(Gdańsk Medical University), Agata Malenda(Instytut Hematologii i Transfuzjologi), Łukasz Bołkuń(Medical University of Białystok), Edyta Cichocka(Nicolaus Copernicus University), Grzegorz Helbig(Medical University of Silesia), Sebastian Grosicki(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Anna Irga-Staniukiewicz(Gdańsk Medical University), Marta Kuydowicz(Medical University of Lodz), Tomasz Gromek(Medical University of Lublin), Michał Łomiak(Instytut Hematologii i Transfuzjologi), Joanna Barankiewicz(Instytut Hematologii i Transfuzjologi), Anna Koclęga(Medical University of Silesia), Sylwia Kościółek- Zgódka(Holy Cross University), Anna Kiżewska(Gdańsk Medical University), Agnieszka Pluta, P. Małecki(Medical University of Silesia), Karol Wójcik
Cited by 1
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k